Literature DB >> 16490253

Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.

Ana S López1, Estibaliz Alegre, Joël LeMaoult, Edgardo Carosella, Alvaro González.   

Abstract

Dendritic cells (DC) are strong inducers of immunity but they can also be tolerogenic. During monocyte differentiation to DC the immunosuppressive indoleamine-2,3-dioxygenase (IDO) is induced. IDO degrades Trp to kynurenine, which is further metabolized to 3-hydroxyanthranilic acid. DC can also express mRNA and protein of the tolerogenic molecule HLA-G, but there is no surface expression. We studied the effect of the Trp degrading pathway on HLA-G expression by DC. When monocytes were differentiated to immature DC in presence of either Trp or its metabolites kynurenine or 3-hydroxyanthranilic acid they expressed cell surface HLA-G, and Trp also increased shedding of HLA-G1. Trp induced HLA-G cell surface expression when present during maturation with IFN-gamma+LPS, but not with TNF-alpha. Kynurenine increased HLA-G expression in both TNF-alpha and IFN-gamma+LPS matured DC, and 3-hydroxyanthranilic acid had a very weak effect on HLA-G cell surface expression when present during maturation. Shedding of HLA-G1 was more pronounced in IFN-gamma+LPS-matured DC than in immatured DC. Maturation with IFN-gamma+LPS in presence of kynurenine also increased HLA-G5 secretion. The mechanism involved seems to be post-translational as mRNA and cellular HLA-G protein content was not increased with Trp, kynurenine or 3-hydroxyanthranilic acid treatments. Finally, immature DC preincubated with Trp, kynurenine and 3-hydroxyanthranilic acid have after a decreased capacity to stimulate T cells in mixed lymphocyte reaction. In IFN-gamma+LPS-matured DC this decreased capacity was obtained with kynurenine and 3-hydroxyanthranilic acid. These results suggest that IDO can induce HLA-G cell surface expression in DC, and that these two molecules can cooperate in the immune suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490253     DOI: 10.1016/j.molimm.2006.01.007

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  22 in total

Review 1.  Dysfunction of antigen processing and presentation by dendritic cells in cancer.

Authors:  Joanna Bandola-Simon; Paul A Roche
Journal:  Mol Immunol       Date:  2018-04-05       Impact factor: 4.407

2.  Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study.

Authors:  V Foschi; D Bortolotti; A F Doyle; V Stratigou; L Stephens; P Trivedi; R Rinaldi; M Padovan; A Bortoluzzi; L Lightstone; T D Cairns; M Botto; T H Cook; R Rizzo; M Govoni; M C Pickering
Journal:  Lupus       Date:  2019-07-10       Impact factor: 2.911

3.  Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands.

Authors:  Daniel O Ochiel; Mimi Ghosh; John V Fahey; Paul M Guyre; Charles R Wira
Journal:  J Leukoc Biol       Date:  2010-04-12       Impact factor: 4.962

Review 4.  The kynurenine system and immunoregulation.

Authors:  Yvette Mándi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-07-09       Impact factor: 3.575

Review 5.  Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditions.

Authors:  Daria Bortolotti; Valentina Gentili; Antonella Rotola; Enzo Cassai; Roberta Rizzo; Dario Di Luca
Journal:  World J Methodol       Date:  2014-03-26

Review 6.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

Review 7.  IDO-expressing regulatory dendritic cells in cancer and chronic infection.

Authors:  Alexey Popov; Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2007-09-18       Impact factor: 4.599

Review 8.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

9.  Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu.

Authors:  Angel Díaz-Lagares; Estibaliz Alegre; Joel LeMaoult; Edgardo D Carosella; Alvaro González
Journal:  Immunology       Date:  2008-09-01       Impact factor: 7.397

Review 10.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.